Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults
2023 · New England Journal of Medicine · 379 citations
https://doi.org/10.1056/nejmoa2307079
J
Jaya Goswami
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
17
Papers
1.0K
Citations
9
h-index
9
i10-index
Jaya Goswami is an academic researcher from Moderna Therapeutics (United States). The author has contributed to research in topics: Respiratory viral infections research & Viral gastroenteritis research and epidemiology & Pneumonia and Respiratory Infections. The author has an h-index of 9, co-authored 15 publications.
Papers by this author
worksSafety and immunogenicity of mRNA-1345 RSV vaccine coadministered with an influenza or COVID-19 vaccine in adults aged 50 years or older: an observer-blinded, placebo-controlled, randomised, phase 3 trial
2024 · The Lancet Infectious Diseases · 21 citations
https://doi.org/10.1016/s1473-3099(24)00589-9
Immune correlates analysis of mRNA-1345 RSV vaccine efficacy clinical trial
2025 · Nature Communications · 10 citations
https://doi.org/10.1038/s41467-025-61153-x
Leveraging Real-World Evidence to Define Severe RSV Lower Respiratory Tract Disease in Adults
2024 · Infectious Diseases and Therapy · 1 citations
https://doi.org/10.1007/s40121-024-01072-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat